WOBURN, Mass.--(BUSINESS WIRE)--Tiffany D. Rau, Ph.D., Senior Consultant at BioProcess Technology Consultants (BPTC), is an organizer of the First Annual Biotechnical Design Competition and a member of the four-judge panel at the Competition finals in October. The remaining three of the initial six international teams, composed of graduate students from Europe and the U.S., will present their designs before delegates attending the 4th European Congress of Applied Biotechnology, October 1-5, 2017, in Barcelona. The competition challenge is to design a complete process for the manufacture of a biosimilar therapeutic.
Speaking on behalf of her fellow organizers, Dr. Rau said, “We see this international competition as a remarkable learning opportunity for these graduate students, especially when one considers that each team is composed of U.S. and European students. Today, biotechnology is a global industry and multinational teams are becoming the norm. I hope we can double the number of participating teams in the near future.”
The Competition is sponsored by the European Society for Biochemical Engineering Sciences (ESBES), in cooperation with the American Chemical Society’s Biochemical Technology Division (ACS-BIOT). Jarka Glassey, ESBES VP and professor at Newcastle University in England, added, “ESBES is delighted with the success of the first design completion, extending the long-term collaboration between ESBES and ACS-BIOT, and look forward to having even greater numbers of European and US graduate student teams.”
Professor William Kelly of Villanova University, a member of the BIOT executive board, said, “This competition provides a unique opportunity for sponsoring companies to engage with some of the brightest future biochemical engineers.”
The design problem for the 2nd Annual Biotechnical Design Competition in 2018 will focus on regenerative medicine.
About BioProcess Technology Consultants
Founded in 1994, BPTC is the recognized worldwide leader in biologics CMC consulting, providing a full range of technical, regulatory, and strategic assistance to pharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company works with clients globally to find and apply solutions to the challenges of biopharmaceutical product development from clone to commercial®. BPTC helps develop manufacturing processes and strategies that enhance the overall value of client companies and accelerate the advancement of new products from clone to clinic®. BPTC also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more information about BPTC, visit http://www.bptc.com. Follow us on Twitter at @bptcGlobal and LinkedIn at https://www.linkedin.com/company-beta/510782.